Soft Market Testing – Pharmacy Aseptic Services Joint Venture

University Hospitals Plymouth NHS Trust (UHP) is exploring options for the development of a new Pharmacy Aseptic Services suite. The proposed facility is intended to provide a comprehensive range of aseptic services including: Chemotherapy preparation Centralised Intravenous Additive Services (CIVAS) Outpatient Antimicrobial Therapy (OPAT/OPIT) support Clinical Trials aseptic support Future-proofed capacity for expected demand growth As part of this appraisal, the Trust is considering a range of potential delivery and funding models, including the possibility of forming a Joint Venture or other partnership with the private sector. The purpose of this soft market testing exercise is to understand: The level of interest from suppliers and investors in partnering with the Trust The range of commercial, technical, and operational models available in the market Key risks, dependencies, and proposed approaches Potential timelines and delivery routes Options that best support service continuity during construction This exercise is not a call for competition, nor part of a formal procurement process. Responses received will help shape the Trust’s strategy and any potential future procurement.